Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
HROW Stock — Harrow, Inc.
Harrow, Inc. (HROW)
Updated October 16, 2026.
HROW is a Stock. Total return is -77.3% over the past 19 years, 674.0 points behind SPY at 596.7%.
Harrow, Inc. is an eyecare pharmaceutical company that discovers, develops, and commercializes ophthalmic drugs through two business segments: branded pharmaceuticals and ImprimisRx, a compounded medications service. The company markets a range of eye care products including biosimilars, anti-inflammatory and antibiotic eye drops, and injectable treatments for conditions such as age-related macular degeneration, diabetic retinopathy, and bacterial conjunctivitis. The company does not currently have an established distribution schedule.
HROW performance versus SPY
Price and return data through 2026-10-16.
Total return is -77.3% over the past 19 years, 674.0 points behind SPY at 596.7%. Over the past year its total return — price change plus distributions reinvested — is -28.1%. Its deepest 1-year drawdown was 50.3%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | -20.3% | — |
| 3M | -39.2% | — |
| 6M | -32.9% | — |
| YTD | -44.3% | — |
| 1Y | -28.1% | — |
| 2Y CAGR | — | -29.50% |
| 3Y CAGR | — | 20.50% |
| 5Y CAGR | — | 22.50% |
| 10Y CAGR | — | 23.30% |
| Since inception (19 years) | -77.3% | -7.50% |
HROW key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 09/28/2007
- Distribution frequency
- None
- Last close
- $27.28 (as of 2026-10-16)
- Market cap
- $1,022,668,548
- Average volume
- 560210.0
- Beta
- 0.185
- Payout ratio
- 0.0%
- Forward P/E
- 46.729
- EPS
- $-0.99
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
HROW risks and drawbacks
Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 50.3%.
Who may consider HROW — and who may not
It is a weaker fit for investors who need monthly cash flow (HROW does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.
More on HROW
Frequently asked questions
Does HROW pay monthly?
No. HROW does not currently distribute.
When does HROW pay a dividend?
HROW does not currently distribute.
How has HROW performed?
Total return is -77.3% over the past 19 years, 674.0 points behind SPY at 596.7%. Over the past year its total return — price change plus distributions reinvested — is -28.1%. Its deepest 1-year drawdown was 50.3%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.